In-House Labs Require Health Investor Due Diligence

Law360, New York (November 20, 2013, 7:21 PM EST) -- In-office laboratories are commonplace in many physician practices today. These laboratories traditionally perform screening or point of care (POC) testing. For screening tests relative to the presence of drugs, such tests are initial, qualitative drug tests conducted to identify classes of drugs present in the urine and typically are done using immunoassay. They rely on a set threshold above which a positive result is produced and therefore do not detect lower concentrations of a drug. While reimbursement for these tests varies by payor, typical reimbursement for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.